Please use this identifier to cite or link to this item: http://docs.prosentient.com.au/prosentientjspui/handle/1/14733
Title: Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14
Authors: Hertzberg M
Gandhi MK
Trotman J
Butcher B
Taper J
Johnston A
Gill D
Ho SJ
Cull G
Fay K
Chong G
Grigg A
Lewis ID
Milliken S
Renwick W
Hahn U
Filshie R
Kannourakis G
Watson AM
Warburton P
Wirth A
Seymour JF
Hofman MS
Hicks RJ; Australasian Leukaemia Lymphoma Group (ALLG).
Issue Date: 2017
Citation: Haematologica. 2017 Feb;102(2):356-363. doi: 10.3324/haematol.2016.154039. Epub 2016 Nov 10.
Journal Title: Haematologica
URI: 
DOI: 10.3324/haematol.2016.154039
Appears in Collections:ISLHD research

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.